Special Issue "Oncogenesis of Pancreatic Cancer: Where Are We"
Deadline for manuscript submissions: 15 May 2024 | Viewed by 1499
Interests: cancer; drug discovery; molecular biology; novel therapeutic strategies; human diseases; pancreatic cancer; liver cancer
Special Issues, Collections and Topics in MDPI journals
Pancreatic cancer is a devastating disease with a 5-year survival rate of just 11% in the USA. It accounts for just 3% of all cancer cases but shares 7% of the total cancer-related deaths. There are several factors responsible for the high mortality of pancreatic cancer patients, such as: late detection, early metastasis, therapy resistance, and cancer-associated cachexia. In the last decade, despite the advancement of our knowledge on the pathogenesis of pancreatic cancer, much remains unexplored regarding the disease progression. A better understanding of the pathogenesis of pancreatic cancer may lead to better management of the disease, leading to improved survival of patients. The aim of the proposed Special Issue is to publish cutting-edge research articles and relevant review articles, which can help to improve our understanding of the progression of pancreatic cancer. I hope this Special Issue will be very useful for the research community and care providers.
Dr. Surendra Shukla
Dr. Tuo Hu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic cancer
- molecular mechanism
- animal models of pancreatic cancer
- cancer pathogenesis
- cancer and muscle wasting